• 1
    Johnston SL. Natural and experimental rhinovirus infections of the lower respiratory tract. Am J Respir Crit Care Med 1995;152:4652.
  • 2
    Wark PA, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 2002;19:6875.
  • 3
    Campbell MJ, Holgate ST, Johnston SL. Trends in asthma mortality. BMJ 1997;315:1012.
  • 4
    Ford ES, Mannino DM, Williams SG. Asthma and influenza vaccination: findings from the 1999–2001 National Health Interview Surveys. Chest 2003;124:783789.
  • 5
    Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 1995;310:12251229.
  • 6
    Doull IJ, Lampe FC, Smith S, Schreiber J, Freezer NJ, Holgate ST. Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial. BMJ 1997;315:858862.
  • 7
    Oommen A, Lambert PC, Grigg J. Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1–5 years: randomised controlled trial. Lancet 2003;362:14331438.
  • 8
    Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 2003; 361: 10711076.
  • 9
    Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, Holgate ST et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002;359:831834.
  • 10
    Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005;201:937947.
  • 11
    Pestka S. The human interferon-a species and hybrid proteins. Semin Oncol 1997;24:S918.
  • 12
    Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004; 202: 832.
  • 13
    Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000;13:539548.
  • 14
    Taniguchi T, Takaoka A. The interferon-α/β system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 2002; 14:111116.
  • 15
    Takaoka A, Hayakawa S, Yanai H, Stoiber D, Negishi H, Kikuchi H et al. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 2003;424:516523.
  • 16
    Gehlhar K, Bilitewski C, Reinitz-Rademacher K, Rohde G, Bufe A. Impaired virus induced IFN-alpha release in adult asthmatic patients. Clin Exp Allergy 2006;36:331337.
  • 17
    Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK et al. IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003; 4:6977.
  • 18
    Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003;4:6368.
  • 19
    Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW et al. Role of deficient type III interferon-λ production in asthma exacerbations. Nat Med 2006;12:10231026.
  • 20
    Laza-Stanca V, Stanciu LA, Message SD, Edwards MR, Gern JE, Johnston SL. Rhinovirus replication in human macrophages induces NF-{kappa}B-dependent tumor necrosis factor alpha production. J Virol 2006; 80: 82488258.
  • 21
    Khaitov MR, Laza-Stantca V, Edwards MR, Johnston SL. Production of alpha-, beta-, and lambda-interferons by epithelial and mononuclear cells during acute respiratory viral infection. Zh Mikrobiol Epidemiol Immunobiol 2006;7:6369 (In Russian).
  • 22
    Bucchieri F, Lordon J, Richter A, Buchanan D, Djukanovic R, Holgate ST et al. Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. Am J Respir Cell Mol Biol 2001;27:179.
  • 23
    Papi A, Johnston SL. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription. J Biol Chem 1999;274:97079720.
  • 24
    Johnston SL, Papi A, Bates PJ, Mastronarde JG, Monick MM, Hunninghake GW. Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. J Immunol 1998;160:61726181.
  • 25
    Spann KM, Tran KC, Chi B, Rabin RL, Collins PL. Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J Virol 2004;78:43634369.
  • 26
    Papadopoulos NG, Johnston SL. Rhinoviruses. In: ZuckermanAJ, BanatvalaJE, PattisonJR, GriffithsPD, SchoubBDeditors. Principles and practice of clinical virology, 5th edn. New York: John Wiley & Sons, Ltd, 2004:361377.
  • 27
    Bergmann M, Garcia-Sastre A, Carnero E, Pehamberger H, Wolff, Palese P et al. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol 2000;74:62036206.
  • 28
    Melville MW, Tan SL, Wambach M, Song J, Morimoto RI, Katze MG. The cellular inhibitor of the PKR protein kinase, P58(IPK), is an influenza virus-activated co-chaperone that modulates heat shock protein 70 activity. J Biol Chem 1999;274:37973803.
  • 29
    Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P et al. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 2000;74:79897996.
  • 30
    Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA et al. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 2000;74:1156611573.
  • 31
    Papadopoulos NG, Bates PJ, Bardin PG, Papi A, Leir SH, Fraenkel DJ et al. Rhinoviruses infect the lower airways. J Infect Dis 2000;181:18751884.
  • 32
    Papadopoulos NG, Mosser AG, Vrtis R, Burchell L, Lee WM, Dick CR et al. Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Am J Respir Crit Care Med 2005; 171: 645651.
  • 33
    Chill JH, Nivasch R, Levy R, Albeck S, Schreiber G, Anglister J. The human interferon receptor: NMR-based modeling, mapping of the IFN-alpha 2 binding site, and observed ligand-induced tightening. Biochemistry 2002;41:35753585.
  • 34
    Chen Y, Hamati E, Lee P, Lee W, Wachi S, Schnurr D et al. rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways. Am J Respir Cell Mol Biol 2006;34:192203.
  • 35
    Lopez-Souza N, Dolganov G, Dubin R, Sachs LA, Sassina L, Sporer H et al. Resistance of differentiated human airway epithelium to infection by rhinovirus. Am J Physiol Lung Cell Mol Physiol 2004;286:373381.
  • 36
    Chu WM, Ostertag D, Li ZW, Chang L, Chen Y, Hu Y et al. JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity 1999;11:721731.
  • 37
    Edwards MR, Johnson MW, Johnston SL. Combination therapy: synergistic suppression of virus induced chemokines in airway epithelial cells. Am J Respir Cell Mol Biol 2006;34:616624.